Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Flexion Therapeutics (NASDAQ: FLXN)

$18.28 USD -$0.46 (-2.45%)
Last Price $18.28
Net Change $-0.46 (-2.45%)
Bid $0
Ask Price $0
Open Price $18.64
Previous Close Price $18.74
High Price $18.76
Low Price $17.89
Number of Trades 1,463
Volume 342,100
Fifty Two Week High $29.41 (2017-03-27)
Fifty Two Week Low $13.1 (2016-06-16)
Average Daily Volume 555,177
Share Outstanding 31,760 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-29.37
Recent Earnings $
Annual EPS $-2.81
Last Quarter EPS $
Market Capitalization $0.58B
Insider Shareholders % 0.18%
Annual Revenue $0B
No. Shares Outstanding 31,760
Inst. Shareholder % 74.24%
Annual Net Income $-0.08B
TTM Net Profit Margin $0
1-Year Return 17.71%
3-Year Return 45.08%
5-Year Return 24.27%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -29.370001%
Dividends per Share $
Stock Split Ratio
Beta 1.19
Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. Flexion Therapeutics, Inc. is headquartered in Burlington, Massachusetts.

FLXN News & Stock Updates